NISA INVESTMENT ADVISORS, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,688
+84300.0%
6780.0%0.00%
Q1 2023$2
-50.0%
6780.0%0.00%
Q4 2022$4
-99.9%
6780.0%0.00%
Q3 2022$7,000
+133.3%
6780.0%0.00%
Q2 2022$3,000
-81.2%
678
-67.4%
0.00%
Q1 2022$16,000
+128.6%
2,078
+206.5%
0.00%
Q4 2021$7,000
-61.1%
678
-50.8%
0.00%
Q3 2021$18,000
-40.0%
1,3780.0%0.00%
Q2 2021$30,000
-9.1%
1,3780.0%0.00%
Q1 2021$33,000
+32.0%
1,3780.0%0.00%
Q4 2020$25,000
+400.0%
1,378
+222.0%
0.00%
Q3 2020$5,000
-50.0%
4280.0%0.00%
Q2 2020$10,000
+100.0%
4280.0%0.00%
Q1 2020$5,000
-28.6%
428
+59.7%
0.00%
Q4 2019$7,000
-98.8%
268
-98.9%
0.00%
-100.0%
Q3 2019$576,000
+3740.0%
25,268
+4953.6%
0.01%
Q2 2019$15,000
+650.0%
500
+233.3%
0.00%
Q1 2019$2,000
-33.3%
1500.0%0.00%
Q4 2018$3,000
-62.5%
1500.0%0.00%
Q3 2018$8,0001500.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 98,482$1,631,0000.60%
Opus Point Partners Management, LLC 20,844$346,0000.47%
HHLR ADVISORS, LTD. 949,431$15,761,0000.44%
Rhenman & Partners Asset Management AB 212,169$3,522,0000.41%
Virtus ETF Advisers LLC 8,654$144,0000.31%
BB BIOTECH AG 671,925$11,154,0000.28%
RA Capital Management 363,051$6,027,0000.26%
BDO Wealth Advisors, LLC 35,234$585,0000.17%
Birchview Capital, LP 15,000$249,0000.16%
SECOR Capital Advisors, LP 37,205$618,0000.13%
View complete list of G1 THERAPEUTICS INC shareholders